Articulação de várias linguagens de programação/tecnologias no desenvolvimento aplicacional

O desenvolvimento aplicacional é uma área em grande expansão no mercado das tecnologias de informação e como tal, é uma área que evolui rápido. Os impulsionadores para esta característica são as comunicações e os equipamentos informáticos, pois detêm características mais robustas e são cada vez mais rápidos. A função das aplicações é acompanhar esta evolução, possuindo arquiteturas mais complexas/completas visando suportar todos os pedidos dos clientes, através da produção de respostas em tempos aceitáveis. Esta dissertação aborda várias arquiteturas aplicacionais possíveis de implementar, mediante o contexto que esteja inserida, como por exemplo, um cenário com poucos ou muitos clientes, pouco ou muito capital para investir em servidores, etc. É fornecido um nivelamento acerca dos conceitos subjacentes ao desenvolvimento aplicacional. Posteriormente é analisado o estado de arte das linguagens de programação web e orientadas a objetos, bases de dados, frameworks em JavaScript, arquiteturas aplicacionais e, por fim, as abordagens para definir objetivos mensuráveis no desenvolvimento aplicacional. Foram implementados dois protótipos. Um deles, numa arquitetura multicamada com várias linguagens de programação e tecnologias. O segundo, numa única camada (monolítica) com uma única linguagem de programação. Os dois protótipos foram testados e comparados com o intuito de escolher uma das arquiteturas, num determinado cenário de utilização.

Host-induced changes in the cell surface N-linked glycoproteins, from Aspergillus fumigatus. Search for specific targets with potential for clinical therapy and/or diagnosis.

This dissertation is presented to obtain a Master degree in Structural and Functional Biochemistry

Post-MAPS: An interactive acquisition platform for gastroenterology

Post-MAPS is a web platform that collects gastroenterological exam data from several european hospital centers, to be used in future clinical studies and was developed in partnership with experts from the gastroenterological area and information technology (IT) technicians. However, although functional, this platform has some issues that are crucial for its functioning, and can render user interaction unpleasant and exhaustive. Accordingly, we proposed the development of a new web platform, in which we aimed for an improvement in terms of usability, data uni cation and interoperability. Therefore, it was necessary to identify and study different ways of acquiring clinical data and review some of the existing clinical databases in order to understand how they work and what type of data they store, as well as their impact and contribution to clinical knowledge. Closely linked to the data model is the ability to share data with other systems, so, we also studied the concept of interoperability and analyzed some of the most widely used international standards, such as DICOM, HL7 and openEHR. As one of the primary objectives of this project was to achieve a better level of usability, practices related to Human Computer-Interaction, such as requirement analysis, creation of conceptual models, prototyping, and evaluation were also studied. Before we began the development, we conducted an analysis of the previous platform, from a functional point of view, which allowed us to gather not only a list of architectural and interface issues, but also a list of improvement opportunities. It was also performed a small preliminary study in order to evaluate the platform's usability, where we were able to realize that perceived usability is different between users, and that, in some aspects, varies according to their location, age and years of experience. Based on the information gathered during the platform's analysis and in the conclusions of the preliminary study, a new platform was developed, prepared for all potential users, from the inexperienced to the most comfortable with technology. It presents major improvements in terms of usability, also providing several new features that simplify the users' work, improving their interaction with the system, making their experience more enjoyable.

Algorithms for information extraction and signal annotation on long-term biosignals using clustering techniques

Dissertação para obtenção do Grau de Mestre em Engenharia Biomédica

A qualitive reasoning approach for improving query results for sketch based queries by topological analysis of spatial aggregation

Dissertation submitted in partial fulfillment of the requirements for the Degree of Master of Science in Geospatial Technologies.

Heterogeneous sensor database framework for the sensor observation service: integrating remote and in-situ sensor observations at the database backend

Dissertation submitted in partial fulfillment of the requirements for the Degree of Master of Science in Geospatial Technologies.

Aplicação do modelo de Elton-Gruber para a construção de carteira no índice PSI-20

Os mercados financeiros têm um papel fundamental na dinamização das economias modernas. Às empresas cotadas oferece o capital necessário para impulsionar o seu crescimento e aos investidores individuais proporciona a diversificação das suas carteiras, usufruindo desta forma do crescimento e da vitalidade da economia mundial. A gestão de carteiras de ativos financeiros constitui uma área que procura apresentar mecanismos para a obtenção de uma relação ótima entre retorno e risco. Neste sentido, inúmeros estudos têm contribuído de forma significativa para a eficiência e para a prática desta técnica. Esta dissertação pretende analisar a metodologia desenvolvida por Elton-Gruber para a construção de carteiras otimizadas e aplicar as técnicas subjacentes ao mercado acionista português. Para o efeito, serão realizadas pesquisas em fontes bibliográficas da especialidade e serão consultadas bases de dados de cotações históricas das ações e do índice de mercado nacional. A aplicação incidiu sobre ações cotadas no índice PSI-20 durante o período compreendido entre 2010 e 2014. No intuito de melhorar a compreensão das séries de retornos das amostras, o estudo de caráter quantitativo também recorreu à análise estatística. As evidências mostram que a carteira otimizada, no período em análise, contém apenas as ações da empresa Portucel. Este resultado estará condicionado pelos efeitos da crise financeira que iniciou em 2008.

Caracterização de perfis pultrudidos Híbridos

A pultrusão é uma técnica já sobejamente conhecida de produção de perfis de secção constante, tais como barras, cantoneiras, perfis estruturais ou tubos, em materiais compósitos de matriz polimérica. A necessidade de, em determinadas aplicações, utilizar perfis que proporcionem melhor isolamento térmico, melhor isolamento acústico ou possuam um momento de inércia ligeiramente superior, sem que o peso próprio seja significativamente afectado, levou à produção de perfis pultrudidos híbridos, com núcleos baseados em pré-formas ou na alimentação contínua de resíduos. Realizados os protótipos seguindo as metodologias acima descritas, urge verificar se as propriedades dos perfis híbridos correspondem às expectativas inicialmente neles depositadas, através de testes destrutivos e não-destrutivos. Assim, foram realizados testes à tracção, à compressão e à flexão, no intuito de verificar os ganhos conseguidos e poder analisar o valor-acrescentado trazido por estes novos perfis em termos estruturais. Estes valores, depois de devidamente validados, permitirão a sua inserção em bases de dados agregadas a programas de cálculo estrutural, que efectuam de forma automática o dimensionamento de estruturas baseadas em perfis desta natureza. Complementarmente, foram realizados testes de isolamento térmico e acústico, com vista a quantificar a melhoria conseguida nestas propriedades, extremamente importantes em determinados tipos de aplicações ligadas à construção civil e obras públicas.

Cancer Rehabilitation Indicators for Europe

Little is known of cancer rehabilitation needs in Europe. EUROCHIP-3 organised a group of experts to propose a list of population-based indicators used for describing cancer rehabilitation across Europe. The aim of this study is to present and discuss these indicators. A EUROCHIP-3 expert panel reached agreement on two types of indicators. (a) Cancer prevalence indicators. These were proposed as a means of characterising the burden of cancer rehabilitation needs by time from diagnosis and patient health status. These indicators can be estimated from cancer registry data or by collecting data on follow-up and treatments for samples of cases archived in cancer registries. (b) Indicators of rehabilitation success. These include: return to work, quality of life, and satisfaction of specific rehabilitation needs. Studies can be performed to estimate these indicators in individual countries, but to obtain comparable data across European countries it will be necessary to administer a questionnaire to randomly selected samples of patients from population-based cancer registry databases. However, three factors complicate questionnaire studies: patients may not be aware that they have cancer; incomplete participation in surveys could lead to bias; and national confidentiality laws in some cases prohibit cancer registries from approaching patients. Although these studies are expensive and difficult to perform, but as the number of cancer survivors increases, it is important to document their needs in order to provide information on cancer control.

Potencial Utilização de um Enterprise Resource Planning System para Suportar Práticas de Gestão de Conhecimento nas Organizações. Uma Aplicação com Dynamics Nav da Microsoft

Dissertação apresentada como requisito parcial para obtenção do grau de Mestre em Estatística e Gestão de Informação

Building clusters for CRM strategies by mining airlines customer data

Trabalho de Projeto apresentado como requisito parcial para obtenção do grau de Mestre em Estatística e Gestão de Informação

Clinical Outcome and Morphologic Determinants of Mural Thrombus in Abdominal Aortic Endografts

OBJECTIVE:Endograft mural thrombus has been associated with stent graft or limb thrombosis after endovascular aneurysm repair (EVAR). This study aimed to identify clinical and morphologic determinants of endograft mural thrombus accumulation and its influence on thromboembolic events after EVAR. METHODS: A prospectively maintained database of patients treated by EVAR at a tertiary institution from 2000 to 2012 was analyzed. Patients treated for degenerative infrarenal abdominal aortic aneurysms and with available imaging for thrombus analysis were considered. All measurements were performed on three-dimensional center-lumen line computed tomography angiography (CTA) reconstructions. Patients with thrombus accumulation within the endograft's main body with a thickness >2 mm and an extension >25% of the main body's circumference were included in the study group and compared with a control group that included all remaining patients. Clinical and morphologic variables were assessed for association with significant thrombus accumulation within the endograft's main body by multivariate regression analysis. Estimates for freedom from thromboembolic events were obtained by Kaplan-Meier plots. RESULTS: Sixty-eight patients (16.4%) presented with endograft mural thrombus. Median follow-up time was 3.54 years (interquartile range, 1.99-5.47 years). In-graft mural thrombus was identified on 30-day CTA in 22 patients (32.4% of the study group), on 6-month CTA in 8 patients (11.8%), and on 1-year CTA in 17 patients (25%). Intraprosthetic thrombus progressively accumulated during the study period in 40 patients of the study group (55.8%). Overall, 17 patients (4.1%) presented with endograft or limb occlusions, 3 (4.4%) in the thrombus group and 14 (4.1%) in the control group (P = .89). Thirty-one patients (7.5%) received an aortouni-iliac (AUI) endograft. Two endograft occlusions were identified among AUI devices (6.5%; overall, 0.5%). None of these patients showed thrombotic deposits in the main body, nor were any outflow abnormalities identified on the immediately preceding CTA. Estimated freedom from thromboembolic events at 5 years was 95% in both groups (P = .97). Endograft thrombus accumulation was associated with >25% proximal aneurysm neck thrombus coverage at baseline (odds ratio [OR], 1.9; 95% confidence interval [CI], 1.1-3.3), neck length ≤ 15 mm (OR, 2.4; 95% CI, 1.3-4.2), proximal neck diameter ≥ 30 mm (OR, 2.4; 95% CI, 1.3-4.6), AUI (OR, 2.2; 95% CI, 1.8-5.5), or polyester-covered stent grafts (OR, 4.0; 95% CI, 2.2-7.3) and with main component "barrel-like" configuration (OR, 6.9; 95% CI, 1.7-28.3). CONCLUSIONS: Mural thrombus formation within the main body of the endograft is related to different endograft configurations, main body geometry, and device fabric but appears to have no association with the occurrence of thromboembolic events over time.

Métodos de avaliação da frequência de eventos adversos em contexto hospitalar : contributos de uma revisão sistemática

RESUMO - Os eventos adversos (EA) hospitalares constituem um problema sério dos cuidados de saúde com consequências clínicas, económicas e sociais para a Saúde Pública. Nas últimas décadas foram realizados diversos estudos com o objetivo de conhecer de forma mais pormenorizada esta realidade, nomeadamente no que diz respeito à frequência, tipologia, evitabilidade e impacte dos EA. De entre as diferentes metodologias que têm sido utilizadas parece existir algum consenso em torno da análise retrospetiva de processos clínicos como a que oferece maior garantia de fiabilidade e reprodutibilidade, não obstante as limitações conhecidas. Assim, propusemo-nos com este trabalho, analisar as vantagens e desvantagens dos métodos mais comummente utilizados para caraterizar a ocorrência de EA e, concomitantemente elaborar uma revisão sistemática (RS) dos estudos que aplicaram o método de revisão retrospetiva de processos clínicos na caraterização e avaliação dos EA em contexto hospitalar. Para definir a nossa amostra, realizámos uma pesquisa formal nas bases de dados MEDLINE e Web of Knowledge, e foi realizado um cruzamento manual de referências dos artigos elegíveis para identificar estudos adicionais relevantes. Os artigos selecionados foram revistos independentemente no que diz respeito à metodologia, aos critérios de elegibilidade e aos objetivos. Durante a fase de revisão e aplicação dos critérios de inclusão e exclusão foram selecionados os artigos que abordassem a frequência/incidência e a percentagem de evitabilidade dos EA hospitalares, através da aplicação do método de revisão retrospetiva de processos clínicos. Após a fase de pesquisa e revisão dos artigos, foram selecionados para a nossa amostra oito estudos que incluíram um total de 28.862 processos clínicos revistos. De entre os principais resultados encontrados destaca-se: i) A mediana de incidência de EA hospitalares de 9.5%; Universidade Nova de Lisboa – Escola Nacional de Saúde Pública ii) O valor de mediana de EA considerados evitáveis de 45.5%; iii) No que se refere ao impacte clínico dos EA, mais de metade dos doentes (56.3%) não experienciou incapacidade ou experienciou incapacidade menor; iv) Em 8% dos casos de EA ocorreu a morte dos doentes. v) Quanto ao impacte económico evidencia-se o facto de, nos doentes em que se confirmou EA, o período de internamento se ter prolongado, em média, por 7.1 dias com consequentes e previsíveis custos adicionais. Tendo em consideração as vantagens e desvantagens de cada método, os sistemas de informação existentes em Portugal e a realidade das instituições de saúde, parece-nos plausível destacar o método de revisão dos processos clínicos como o que melhor se adapta para caraterizar os EA no contexto hospitalar português.

Novel FGFR1 Mutations in Kallmann Syndrome and Normosmic Idiopathic Hypogonadotropic Hypogonadism: Evidence for the Involvement of an Alternatively Spliced Isoform

OBJECTIVE: To determine the prevalence of fibroblast growth factor receptor 1 (FGFR1) mutations and their predicted functional consequences in patients with idiopathic hypogonadotropic hypogonadism (IHH). DESIGN: Cross-sectional study. SETTING: Multicentric. PATIENT(S): Fifty unrelated patients with IHH (21 with Kallmann syndrome and 29 with normosmic IHH). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Patients were screened for mutations in FGFR1. The functional consequences of mutations were predicted by in silico structural and conservation analysis. RESULT(S): Heterozygous FGFR1 mutations were identified in six (12%) kindreds. These consisted of frameshift mutations (p.Pro33-Alafs*17 and p.Tyr654*) and missense mutations in the signal peptide (p.Trp4Cys), in the D1 extracellular domain (p.Ser96Cys) and in the cytoplasmic tyrosine kinase domain (p.Met719Val). A missense mutation was identified in the alternatively spliced exon 8A (p.Ala353Thr) that exclusively affects the D3 extracellular domain of FGFR1 isoform IIIb. Structure-based and sequence-based prediction methods and the absence of these variants in 200 normal controls were all consistent with a critical role for the mutations in the activity of the receptor. Oligogenic inheritance (FGFR1/CHD7/PROKR2) was found in one patient. CONCLUSION(S): Two FGFR1 isoforms, IIIb and IIIc, result from alternative splicing of exons 8A and 8B, respectively. Loss-of-function of isoform IIIc is a cause of IHH, whereas isoform IIIb is thought to be redundant. Ours is the first report of normosmic IHH associated with a mutation in the alternatively spliced exon 8A and suggests that this disorder can be caused by defects in either of the two alternatively spliced FGFR1 isoforms.

Recommendations for Vaccination in Adult Patients with Systemic Inflammatory Rheumatic Diseases from the Portuguese Society of Rheumatology

Serious infections are a major cause of morbidity and mortality in systemic inflammatory rheumatic disease (SIRD) patients. Although vaccination may prevent numerous infections, vaccination uptake rates are low in this group of patients. OBJECTIVES: To develop evidence-based recommendations for vaccination in SIRD patients. METHODS: We searched MEDLINE (until 31 October 2014) and EMBASE (until 14 December 2014) databases, as well as the ACR and EULAR congress abstracts (2011-2014). Patients with any systemic inflammatory rheumatic disease were included and all vaccines were considered. Any safety and efficacy outcomes were admitted. Search results were submitted to title and abstract selection, followed by detailed review of suitable studies. Data were subsequently pooled according to the type of vaccine and the SIRD considered. Results were presented and discussed by a multidisciplinary panel and systematic literature review (SLR)-derived recommendations were voted according to the Delphi method. The level of agreement among rheumatologists was assessed using an online survey. RESULTS: Eight general and seven vaccine-specific recommendations were formulated. Briefly, immunization status should routinely be assessed in all SIRD patients. The National Vaccination Program should be followed and some additional vaccines are recommended. To maximize the efficacy of vaccination, vaccines should preferably be administered 4 weeks before starting immunosuppression or, if possible when disease activity is controlled. Non-live vaccines are safe in SIRD, including immunosuppressed patients. The safety of live attenuated vaccines in immunosuppressed patients deserves further ascertainment, but might be considered in particular situations. DISCUSSION: The present recommendations combine scientific evidence with the multidisciplinary expertise of our taskforce panel and attained desirable agreement among Portuguese rheumatologists. Vaccination recommendations need to be updated on a regular basis, as more scientific data regarding vaccination efficacy and safety, emergent infectious threats, new vaccines as well as new immunomodulatory therapies become available.